3SBio (TRSBF) Stock Price, News & Analysis

Company Overview

3SBio Inc. is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of biologic medicines. Its portfolio primarily serves therapeutic areas including nephrology, oncology, autoimmune diseases and other conditions requiring specialized biologic treatments.

The company’s products include recombinant human erythropoietin products used to treat anemia, recombinant human growth hormone, and thrombopoietin therapies designed to support platelet production. 3SBio also markets biologic treatments such as etanercept for autoimmune conditions and continues to develop additional therapies through internal research and strategic partnerships.

Founded in 1993, 3SBio is headquartered in Shenyang, China, and has built a commercial presence in China while pursuing selected international opportunities. The company is listed on the Hong Kong Stock Exchange and is represented in the U.S. over the counter under the symbol TRSBF.

Key Stats

• Today's Range: $2.15 to $2.15
• 50-Day Range: $2.12 to $2.15
• 52-Week Range: $2.00 to $4.74
• Volume: N/A
• Average Volume: 2,351 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:TRSBF
• CIK: N/A
• Web: www.3sbio.com
• Phone: 86 24 2538 6000
• Fax: N/A
• Employees: 5,411
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A